Laboratory features of tumour lysis syndrome following daratumumab monotherapy in relapsed/refractory multiple myeloma

EJHaem. 2020 Jul 4;1(1):312-314. doi: 10.1002/jha2.34. eCollection 2020 Jul.

Authors

Louisa Shackleton¹, James Fay¹, Elizabeth Smyth¹, Philip Murphy¹, Siobhan Glavey¹, John Quinn¹

Affiliation

¹ Department of Haematology Beaumont Hospital Dublin Ireland.

PMID: 35847740
PMCID: PMC9176006
DOI: 10.1002/jha2.34

No abstract available

Publication types

Case Reports